Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cephalalgia

• Publication date

  2017-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0333102415625614PMID 26888294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2015cited by this paper
• Glutamate and migraine: From Ikeda to the 21st century

  2014cited by this paper
• Is β endorphin related to migraine headache and its relief?

  2013cited by this paper
• Pathophysiology of Migraine.

  2013cited by this paper
• Pathophysiology of migraine.

  2013cited by this paper
• Fluid biomarkers in Alzheimer’s disease – current concepts

  2013cited by this paper
• Glutamate oxaloacetate transaminase: A new key in the dysregulation of glutamate in migraine patients

  2013cited by this paper
• Analysis of endothelial precursor cells in chronic migraine: A case-control study

  2013cited by this paper
• Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a case–control study

  2013cited by this paper
• Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

  2013cited by this paper
• Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

  2013cited by this paper
• Bias in associations of emerging biomarkers with cardiovascular disease.

  2013cited by this paper
• What do plasma beta‐endorphin levels reveal about endogenous opioid analgesic function?

  2012cited by this paper
• Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF

  2012cited by this paper
• Endothelial progenitor cells

  2012cited by this paper
• Implementation of proteomic biomarkers: making it work

  2012cited by this paper
• One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010

  2011cited by this paper
• Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients.

  2011cited by this paper
• Cerebrospinal fluid phospholipase C activity increases in migraine

  2011cited by this paper
• The Epidemiology of Primary Headache Disorders

  2010influential reference
• CGRP and its receptors provide new insights into migraine pathophysiology

  2010influential reference
• A Remarkable Increase in Total Homocysteine Concentrations in the CSF of Migraine Patients With Aura

  2010cited by this paper
• Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period

  2009cited by this paper
• Effective Prophylactic Treatments of Migraine Lower Plasma Glutamate Levels

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Cerebrospinal Fluid Cytokine Levels in Migraine, Tension-Type Headache and Cervicogenic Headache

  2009cited by this paper
• Plasma Calcitonin Gene-Related Peptide in Diagnosing and Predicting Paediatric Migraine

  2009cited by this paper
• Involvement of Corticotrophin-Releasing Factor and Orexin-A in Chronic Migraine and Medication-Overuse Headache: Findings From Cerebrospinal Fluid

  2008cited by this paper
• Cerebrospinal Fluid and Serum Neuron-Specific Enolase in Acute Benign Headache

  2008cited by this paper
• Elevation of CSF Tumor Necrosis Factor α Levels in New Daily Persistent Headache and Treatment Refractory Chronic Migraine

  2008cited by this paper
• Platelet Glutamate Uptake and Release in Migraine With and Without Aura

  2007cited by this paper
• Elevation of CSF Tumor Necrosis Factor α Levels in New Daily Persistent Headache and Treatment Refractory Chronic Migraine

  2007cited by this paper
• Glutamate Levels in Cerebrospinal Fluid and Triptans Overuse in Chronic Migraine

  2007cited by this paper
• Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache‐free periods

  2007cited by this paper
• Endocannabinoids in Chronic Migraine: CSF Findings Suggest a System Failure

  2007cited by this paper
• Endocannabinoids in Chronic Migraine: CSF Findings Suggest a System Failure

  2007cited by this paper
• Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome.

  2007cited by this paper
• Peripheral Levels of BDNF and NGF in Primary Headaches

  2006cited by this paper
• PATHOPHYSIOLOGY OF MIGRAINE

  2006influential reference
• Glial Cell Line-Derived Neurotrophic Factor and Somatostatin Levels in Cerebrospinal Fluid of Patients Affected by Chronic Migraine and Fibromyalgia

  2006cited by this paper
• Cerebrospinal fluid GABA levels in chronic migraine with and without depression.

  2006cited by this paper
• Cerebrospinal Fluid Sodium Increases in Migraine

  2006cited by this paper
• The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse Headache

  2005cited by this paper
• Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion

  2005cited by this paper
• Molecular mechanisms of cerebrospinal fluid production.

  2004cited by this paper
• Cerebrospinal Fluid Glutamate Levels in Chronic Migraine

  2004cited by this paper
• Glutamate and Nitric Oxide Pathway in Chronic Daily Headache: Evidence From Cerebrospinal Fluid

  2003cited by this paper
• Glial cell line‐derived neurotrophic factor increases calcitonin gene‐related peptide immunoreactivity in sensory and motoneurons in vivo

  2003cited by this paper
• Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants.

  2003cited by this paper
• Brain-derived neurotrophic factor in cerebrospinal fluid of patients with chronic daily headache: relationship with nerve growth factor and glutamate levels

  2002cited by this paper
• Nerve growth factor signaling, neuroprotection, and neural repair.

  2001cited by this paper
• CSF hypocretin/orexin levels in narcolepsy and other neurological conditions

  2001cited by this paper
• Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients

  2001cited by this paper
• Phases of biomarker development for early detection of cancer.

  2001cited by this paper
• Evidence for increased plasma levels of calcitonin gene‐related peptide in migraine outside of attacks

  2000cited by this paper
• Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF.

  2000cited by this paper
• Brain-Derived Neurotrophic Factor Modulates Nociceptive Sensory Inputs and NMDA-Evoked Responses in the Rat Spinal Cord

  1999cited by this paper
• Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache.

  1998cited by this paper
• BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities.

  1998cited by this paper
• Erythrocyte and Plasma Levels of Glutamate and Aspartate in Children Affected by Migraine

  1997cited by this paper
• Cerebrospinal Fluid Tyrosine and 3,4-Dihydroxyphenylacetic Acid Levels in Migraine Patients

  1996cited by this paper
• β‐Endorphin in Plasma and Monocytes in Juvenile Headache

  1996cited by this paper
• Vasoactive Peptide Levels in The Plasma of Young Migraine Patients With and Without Aura Assessed Both Interictally and Ictally

  1995cited by this paper
• Cerebrospinal Fluid Analyses in Migraine Patients and Controls

  1995cited by this paper
• Platelet and Plasma Levels of Glutamate and Glutamine in Migraine With and Without Aura

  1995cited by this paper
• Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia

  1994cited by this paper
• Classification of Daily and Near‐Daily Headaches: Proposed Revisions to the IHS Criteria

  1994cited by this paper
• Taurine Levels in Plasma and Cerebrospinal Fluid in Migraine Patients

  1993cited by this paper
• Catecholamine levels in plasma and CSF in migraine.

  1993cited by this paper
• Neuroexcitatory Amino Acid Levels in Plasma and Cerebrospinal Fluid During Migraine Attacks

  1993cited by this paper
• Evidence of alpha-N-acetyl β-endorphin in human cerebrospinal fluid

  1992cited by this paper
• Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine.

  1992cited by this paper
• Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid.

  1992cited by this paper
• Hormonal changes in headache patients.

  1991cited by this paper
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  1990cited by this paper
• Effects of behaviour therapy on migraine and plasma β-endorphin in young migraine patients

  1990cited by this paper
• Neuroexcitatory plasma amino acids are elevated in migraine

  1990cited by this paper
• Effects of behaviour therapy on migraine and plasma beta-endorphin in young migraine patients.

  1990cited by this paper
• Premenstrual failure of alpha‐adrenergic stimulation on hypothalamus‐pituitary responses in menstrual migraine.

  1989cited by this paper
• Cerebrospinal Fluid (CSF) Investigations in Migraine

  1989cited by this paper
• A Neuroendocrinological Study in Female Migraineurs: Prolactin and Thyroid Stimulating Hormone Responses

  1989cited by this paper
• Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine.

  1989cited by this paper
• Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

  1988cited by this paper
• Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study

  1988cited by this paper
• Pattern of plasma opioids in menstrually-related migraine and epilepsy.

  1986cited by this paper
• Simultaneous determination of radio-immunoassayable methionine-enkephalin and radioreceptor-active opiate peptides in CSF of chronic pain suffering and non suffering patients.

  1986cited by this paper
• CSF β-EP in Headache and Depression

  1985cited by this paper
• CSF beta-EP in headache and depression.

  1985cited by this paper
• Plasma and CSF Endorphin Levels in Primary and Symptomatic Headaches

  1985cited by this paper
• Endorphin Levels in Headache Syndromes

  1985cited by this paper
• Progressive impairment of CSF beta-EP levels in migraine sufferers.

  1984cited by this paper
• Progressive impairment of CSF &bgr;‐EP levels in migraine sufferers

  1984cited by this paper
• Circadian variations of proopiocortin-related peptides in children with migraine

  1983cited by this paper
• Intermittent Hypoendorphinaemia in Migraine Attack

  1982cited by this paper
• A putative 5-HT central feedback in migraine and cluster headache attacks.

  1982cited by this paper
• Primary Headaches: Reduced Circulating β-Lipotropin and β-Endorphin Levels with Impaired Reactivity to Acupuncture

  1981cited by this paper
• Primary headaches: reduced circulating beta-lipotropin and beta-endorphin levels with impaired reactivity to acupuncture.

  1981cited by this paper
• Endogenous Opioids in Cerebrospinal Fluid and Blood in Idiopathic Headache Sufferers

  1980cited by this paper
• BIOCHEMICAL COMPARISON OF MIGRAINE AND STROKE

  1976cited by this paper
• Cerebrospinal fluid gamma aminobutyric acid levels in migraine.

  1975cited by this paper

• Meningeal neuropeptide and neuroimmune interactions in the context of migraine.

  2026cites this paper
• Fine-mapping a genome-wide meta-analysis of 98,374 migraine cases identifies 181 sets of candidate causal variants

  2026cites this paper
• Association between liver enzyme levels and prevalence of migraine: the atherosclerosis risk in communities study

  2025cites this paper
• miR-197, miR-101, and miR-143 and Pro-Inflammatory Cytokines in Migraine

  2025cites this paper
• Cannabinoids rescue migraine symptoms caused by central CGRP administration in mice

  2025cites this paper
• Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in Japan.

  2025cites this paper
• Clinical Characteristics of Migraine and Serum Beta-Endorphin Levels in Undergraduate Students in Osun State, Nigeria

  2025cites this paper
• Calcitonin gene-related peptide concentration in cerebrospinal fluid and serum in horses affected by trigeminal-mediated headshaking.

  2025cites this paper
• Targeting the microbiome in pediatric migraine: gastrointestinal manifestations and the therapeutic role of Bifidobacterium longum

  2025cites this paper
• Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders: A Cross-Sectional Study

  2025cites this paper
• Correlation of Amine Concentrations in Blood and Cerebrospinal Fluid in Healthy Volunteers and Migraineurs

  2025cites this paper
• Effects of lumbar stabilization exercises on serum biomarker levels and clinical outcomes in lumbar disc herniation: a subgroup analysis of a randomized controlled trial

  2025cites this paper
• Calcitonin gene-related peptide (CGRP) in the pathophysiology of gastrointestinal disorders - A key mediator in the gut-brain axis.

  2025cites this paper
• Calcitonin gene-related peptide in newly diagnosed idiopathic intracranial hypertension: a prospective, cross-sectional, case-control study of cerebrospinal fluid and plasma

  2025cites this paper
• Biomarkers in headaches as a potential solution to simplify differential diagnosis of primary headache disorders: a systematic review

  2025cites this paper
• Inflammatory and Analgesic Profiles in Intervertebral Disc Herniation: Variability with Respect to Neurological Deficit.

  2025cites this paper
• Could glutamate be a diagnostic marker in neurological and psychiatric diseases?

  2025cites this paper
• Glutamate as a Therapeutic Substrate in Migraine

  2025cites this paper
• Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine

  2025cites this paper
• Evidence‐based review and frontiers of migraine therapy

  2024cites this paper
• Bimodal functions of calcitonin gene-related peptide in the brain.

  2024cites this paper
• Research trends and hotspots in clinical trials of migraine in the past 20 years: bibliometric analysis

  2024cites this paper
• Deep and unbiased proteomics, pathway enrichment analysis, and protein–protein interaction of biomarker signatures in migraine

  2024cites this paper
• Volume changes of deep brain structures in episodic migraine

  2024cites this paper
• Biomarkers and Endophenotypes of Post-traumatic Headaches

  2024cites this paper
• Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model

  2024cites this paper
• Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study

  2024cites this paper
• Altered immunity in migraine: a comprehensive scoping review

  2024cites this paper
• Fine-mapping a genome-wide meta-analysis of 98,374 migraine cases identifies 181 sets of candidate causal variants

  2024cites this paper
• Task-related brain activation associated with violence in patients with schizophrenia: A meta-analysis.

  2024cites this paper
• Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies

  2024cites this paper
• Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization

  2024cites this paper
• Understanding the Biological Relationship between Migraine and Depression

  2024cites this paper
• Migraine - a borderland disease to epilepsy: near it but not of it

  2024cites this paper
• IUPHAR Review: Navigating the role of preclinical models in pain research.

  2024cites this paper
• Depression and treatment with anti‐calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine

  2023cites this paper
• Effectiveness of integrated approach of yoga therapy versus usual care in management on chronic low back pain patients: A randomized controlled pilot study

  2023cites this paper
• Serological Biomarkers of Chronic Migraine

  2023cites this paper
• Major Targets involved in Clinical Management of Migraine.

  2023cites this paper
• Aberrant brain structure in patients with schizophrenia and violence: A meta-analysis.

  2023cites this paper
• Altered interictal serum histamine and immunoglobulin E but unchanged tryptase levels in individuals with episodic and chronic migraine

  2023cites this paper
• Serum Alpha and Beta‐CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its Receptor

  2023cites this paper
• Serum alpha-CGRP levels are increased in COVID-19 patients with headache indicating an activation of the trigeminal system

  2023cites this paper
• Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings

  2023cites this paper
• Migraine genetics: Status and road forward

  2023cites this paper
• Calcitonin Gene-Related Peptide and Trigeminal Neuralgia

  2023cites this paper
• Current Update on Categorization of Migraine Subtypes on the Basis of Genetic Variation: a Systematic Review

  2023cites this paper
• Novel FDA-approved zavegepant drug for treating migraine

  2023cites this paper
• Exploring the causal relationship between inflammatory cytokines and migraine: a bidirectional, two-sample Mendelian randomization study

  2023cites this paper
• Receiving Medical Care for Chronic Migraines: A Phenomenological Study

  2022cites this paper
• Interictal plasma endothelin-1 levels do not change in individuals with episodic and chronic migraine

  2022cites this paper
• Effectiveness of Integrated Approach of Yoga Therapy (IAYT) Versus Usual Care in Management on Chronic Low Back Pain Patients: a Randomized Controlled Pilot Study

  2022cites this paper
• Neurobiology of migraine progression

  2022cites this paper
• CGRP: A New Endogenous Cell Stemness Maintenance Molecule

  2022cites this paper
• Cerebrospinal Fluid and Plasma Amine Profiles in Interictal Migraine

  2022cites this paper
• CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

  2022cites this paper
• Migraine Pathophysiology Revisited: Proposal of a New Molecular Theory of Migraine Pathophysiology and Headache Diagnostic Criteria

  2022cites this paper
• Involvement of the cerebellum in migraine

  2022cites this paper
• No change in interictal C-reactive protein levels in individuals with episodic and chronic migraine: A case-control study and literature review

  2022cites this paper
• Focus on zavegepant: the first intranasal third-generation gepant.

  2022cites this paper
• Immunologic aspects of migraine: A review of literature

  2022cites this paper
• Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine

  2022cites this paper
• Study of clinical correlation of motion sickness in patients with vestibular migraine

  2022cites this paper
• Hypoxia-related mechanisms inducing acute mountain sickness and migraine

  2022cites this paper
• Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine

  2022cites this paper
• A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine.

  2022cites this paper
• Relating the cortical visual contrast gain response to spectroscopy-measured excitatory and inhibitory metabolites in people who experience migraine

  2022cites this paper
• Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy

  2021cites this paper
• Green Flags and headache: A concept study using the Delphi method

  2021cites this paper
• Comparative evaluation of serum calcitonin gene related peptide level in patients with migraine headache with and without aura

  2021cites this paper
• Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema

  2021cites this paper
• The role of a potential biomarker in patients with migraine: review and new insights

  2021cites this paper
• Headache Medicine Grand Challenge: Headache: A New Frontier, A New Challenge

  2021cites this paper
• CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater

  2021cites this paper
• A Prescription for Exercise

  2021cites this paper
• BRAIN MAGNETIC RESONANCE SPECTROSCOPY IN MIGRAINE

  2021cites this paper
• A review of migraine genetics: gathering genomic and transcriptomic factors

  2021cites this paper
• Comparison of the Effect of Core Stability and Suspension Training on Beta Endorphin, Pain, and Functional Disability in Patients with Lumbar Disc Herniation: A Clinical Trial

  2021cites this paper
• Cortical glutamate and gamma-aminobutyric acid over the course of a provoked migraine attack, a 7 Tesla magnetic resonance spectroscopy study

  2021cites this paper
• A replication study separates polymorphisms behind migraine with and without depression

  2021cites this paper
• Calcitonin Gene-Related Peptide (CGRP) and Cluster Headache

  2020cites this paper
• NDT_A_255717 1845..1852

  2020cites this paper
• Approaching the child with headache

  2020cites this paper
• Identification and quantification of the quality markers and anti-migraine active components in Chuanxiong Rhizoma and Cyperi Rhizoma herbal pair based on chemometric analysis between chemical constituents and pharmacological effects.

  2020cites this paper
• How does the brain change in chronic migraine? Developing disease biomarkers

  2020cites this paper
• Síntomas parasimpáticos craneales en pacientes con migraña crónica y correlación con biomarcadores

  2020influential citation
• α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia

  2020cites this paper
• A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.

  2020cites this paper
• Effects of estrogen and progesterone on the neurogenic inflammatory neuropeptides: implications for gender differences in migraine

  2020cites this paper
• Review of aromatherapy essential oils and their mechanism of action against migraines.

  2020cites this paper
• A Novel Diagnostic Prediction Model for Vestibular Migraine

  2020cites this paper
• Migraine and Two-Pore-Domain Potassium Channels

  2020cites this paper
• Efficacy and safety of the classic chinese herbal prescription sanpian decoction on migraine: Meta-analysis.

  2020cites this paper
• Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case‐Control and Case‐Crossover Settings: A Systematic Review and Meta‐Analysis

  2020cites this paper
• Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting

  2020cites this paper
• Inhibition of Nerve Growth Factor Signaling Alleviates Repeated Dural Stimulation-induced Hyperalgesia in Rats.

  2019cites this paper
• El péptido en relación con el gen de la calcitonina como potencial biomarcador de la migraña crónica

  2019cites this paper
• Couples Living with Chronic Migraines: A Phenomenological Study

  2019cites this paper
• Involvement of CGRP receptor RAMP1 in cluster headache: A Swedish case-control study

  2019cites this paper
• Regulation of CSF and Brain Tissue Sodium Levels by the Blood-CSF and Blood-Brain Barriers During Migraine

  2019cites this paper